Q1 2025 Earnings Call Transcript April 29, 2025 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0 ...

Recent developments in health highlight key agreements between countries, drug approvals, corporate revenue growth, and ...

At this year's South by Southwest (SXSW) conference in Austin, Texas, Future Today Strategy Group founder and CEO Amy Webb ...

Fueled by a unique blend of innovation, talent, and collaboration, Austin has built a reputation as a tech powerhouse, but ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

Protein Engineering Market IntroductionThe protein engineering market is rapidly evolving, driven by the need to develop proteins with improved functionality for a range of applications, including ...

We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking ...

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...

As reported in our April 25, 2025, blog item, the National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final report and action plan, “ur ...

An international research team led by Professor Kiavash Movahedi from the Brussels Center for Immunology at the Vrije ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Traditional biochemical methods of studying human gene mutations are often laborious and costly. Now bioengineers at the ...